Thirteen new MELs (DRGs) were introduced into the LKF 2020 model for the inpatient and outpatient settings.

On May 7, 2020, the National Association of Statutory Health Insurance Physicians (KBV) announced that antibodies testing for COVID-19 will be reimbursement. The findings of the test must be communicated within 24 hours.

In late April 2020, the European Parliament has postponed the come-into-force of the EU Medical Device Regulation (MDR) by one year. Medical devices can thus be placed on the market for another year under the previous regulations. The end date of the transition period will remain May 26, 2024.

On 10 April 2020, the Reimbursement Commission made changes to the SUT regarding response to the COVID-19 pandemic and introduced procedure codes regarding pandemic care service (including pandemic care service for ICU care and immune plasma supply and application).

Twenty-five new diagnosis codes were implemented and changed in the Austrian version of ICD-10 2020 of the LKF model 2020

The French High Authority for Health (HAS) regularly publishes new decisions about add-on reimbursement for medical devices. The decisions made in April 2020 concern various types of devices, for example, cardiovascular and orthopaedic devices, diabetes management systems, and other types of devices. A total of 15 decisions were made.

The corresponding decision by the (the Federal Joint Committee) of January 16, 2020, was published in the Federal Gazette and came into force on April 9, 2020.

On April 1, 2020, Minister of Health, Welfare, and Sport decided to secure a total of €42 million for studying the most urgent corona-related issues. It is estimated that these additional funds will enable 80 - 100 evaluations to be carried out. The Dutch Research Council (NWO) and the Dutch Organization for Health Research and Development (ZonMW) will work together on the research programs.

NHSX provides funding through 'Techforce 19' to innovators who can find digital ways to benefit those in need of help, including those in need of mental health support and social care. The technology is intended to help people who might be most impacted by the long term effects of remaining housebound during the COVID-19 pandemic.

On April 27, 2020, the Italian Ministry of Health shared the invitation of the Italian “Alliance against cancer,” which is intended for all the interested companies that wish to participate in the CAR-T research project.

In March-April, MTRC introduced a number of changes in the educational seminars on reimbursement systems in the Czech Republic and England and released additional modules about reimbursement of in-vitro diagnostic tests in Russia and Turkey.

MTRC continues releasing new seminars on the topics on market access. The seminar discusses key stakeholders, money flow, reimbursement in ambulatory settings for IVD tests, national and regional Benefit Catalogs and the role of HTA for market access of IVD tests.